Skip to content
Terri McVeigh 310x360

Dr Terri McVeigh

The Royal Marsden NHS Foundation Trust, London

Dr Terri McVeigh is a Consultant Clinical Geneticist in the Royal Marsden NHS Foundation Trust, specialising in Cancer Genetics.
Dr McVeigh undertook undergraduate medical training, postgraduate core surgical training and Higher Specialist Training in Clinical Genetics in Ireland. Her specialist training was funded by the Health Research Board/Health Service Executive National Academic SpR Fellowship Programme, with research fellowships in Yale University, New Haven, USA, and in QIMR Berghofer, Brisbane Australia. She also undertook a Clinical Research Fellowship in the Royal Marsden NHS Foundation Trust, and subsequently took up a consultant post there in 2018.
She was awarded a PhD from National University of Ireland, Galway for her work investigating the translational applications of genomic profiling for risk estimation, prognostication and treatment of breast cancer. She also holds a Certificate in Medical Genetics (RCPath) and Postgraduate Diploma in Medical Science (NUI Galway).
Dr McVeigh has a special interest in teaching, and holds a Masters in Clinical Education. Dr McVeigh has developed a fully online postgraduate certificate in Cancer Genetics with the Royal College of Physicians of Ireland. She also acts as a core tutor on the Postgraduate Diploma in Clinical Education in NUI Galway, as well as on the Molecular Pathology of Cancer and Application in Cancer Diagnosis, Screening, and Treatment Module of the ICR -led MSc in Genomic Medicine (Imperial College London). She regularly supervises and examines postgraduate research projects.
Dr McVeigh keenly supports patient engagement and education. She developed and curates a patient information website (www.cancergenetics.ie). She is also a member of the medical advisory board of the Ovacome Ovarian Cancer charity in the UK.
She is a member of the Council and deputy chair of Social Media/Communications committee of the Cancer Genetics Group of the British Society of Genomic Medicine.